• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    More On BICL.TA

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    BioCancell Ltd. (BICL.TA)

    -Tel Aviv
    94.50 Down 0.70(0.74%) Apr 21, 10:24AM EDT
    Add to Portfolio
    Prev Close:94.50
    Open:93.00
    Bid:94.90
    Ask:95.70
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:92.00 - 96.00
    52wk Range:0.92 - 96.00
    Volume:58,330
    Avg Vol (3m):40,780
    Market Cap:2.93B
    P/E (ttm):N/A
    EPS (ttm):-0.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in ILS.

    Headlines

    » More Headlines for BICL.TA

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioCancell Ltd., a biotechnology research and development company, develops drugs for treating various types of cancer. Its lead drug-candidate is BC-819, which is used for the treatment of bladder cancer. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback